Abstract | BACKGROUND: METHODS: This is a prospective randomized study at a university hospital. Fourteen neonates were randomized to intraoperative and postoperative conventional insulin therapy or TGC. Study endpoints were effects on myocardial damage and function; inflammation, endothelial activation, and clinical outcome parameters. RESULTS: CONCLUSIONS: In neonates undergoing cardiac surgery, intraoperative and postoperative TGC protects the myocardium and reduces the inflammatory response. This appears not to be mediated by an early, direct insulin signaling effect, but may rather be due to independent effects of preventing hyperglycemia during reperfusion.
|
Authors | Dirk Vlasselaers, Dieter Mesotten, Lies Langouche, Ilse Vanhorebeek, Ingeborg van den Heuvel, Ilse Milants, Pieter Wouters, Patrick Wouters, Bart Meyns, Mette Bjerre, Troels Krarup Hansen, Greet Van den Berghe |
Journal | The Annals of thoracic surgery
(Ann Thorac Surg)
Vol. 90
Issue 1
Pg. 22-9
(Jul 2010)
ISSN: 1552-6259 [Electronic] Netherlands |
PMID | 20609741
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright 2010 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved. |
Chemical References |
- Blood Glucose
- Hypoglycemic Agents
- Insulin
|
Topics |
- Blood Glucose
(metabolism)
- Cardiac Surgical Procedures
(adverse effects)
- Critical Illness
(therapy)
- Heart Defects, Congenital
(blood, surgery)
- Humans
- Hyperglycemia
(etiology, metabolism)
- Hypoglycemic Agents
(administration & dosage)
- Infant, Newborn
- Insulin
(administration & dosage)
- Myocardial Reperfusion Injury
(blood, metabolism, prevention & control)
- Myocardium
(metabolism)
- Prospective Studies
- Systemic Inflammatory Response Syndrome
(etiology, metabolism, prevention & control)
|